Skip to main content
logo
G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
34.30
-0.70 (-2.00%)
May 8, 2026, 1:30 PM CST

G&E Herbal Biotechnology Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,1862,7343,3393,4402,9721,558
Market Cap Growth
-25.16%-18.14%-2.92%15.73%90.71%-19.66%
Enterprise Value
1,7562,3233,0173,2262,8491,446
Last Close Price
34.3042.9051.6552.6745.5123.86
PE Ratio
15.7319.6432.7247.51402.69-
PS Ratio
7.078.8413.4118.9646.0163.43
PB Ratio
2.352.954.014.514.302.28
P/TBV Ratio
2.753.444.775.475.342.84
P/FCF Ratio
32.6340.8225.9431.8630.64-
P/OCF Ratio
31.1438.9524.8030.3129.73-
EV/Sales Ratio
5.687.5212.1217.7844.1058.83
EV/EBITDA Ratio
10.7814.3423.3535.88191.43-
EV/EBIT Ratio
11.5315.2525.2239.98519.39-
EV/FCF Ratio
26.2234.6923.4429.8829.37-
Debt / Equity Ratio
0.000.000.000.00--
Debt / EBITDA Ratio
0.010.010.010.02--
Debt / FCF Ratio
0.010.010.010.02--
Net Debt / Equity Ratio
-0.46-0.46-0.49-0.41-0.30-0.16
Net Debt / EBITDA Ratio
-2.65-2.65-3.15-3.46-13.8410.65
Net Debt / FCF Ratio
-6.41-6.41-3.16-2.88-2.129.93
Asset Turnover
0.320.320.270.220.090.04
Inventory Turnover
1.951.951.961.551.140.81
Quick Ratio
9.519.513.422.772.2513.14
Current Ratio
10.0910.093.612.972.5415.66
Return on Equity (ROE)
15.80%15.80%12.78%9.96%1.07%-2.87%
Return on Assets (ROA)
9.84%9.84%8.12%6.05%0.46%-1.74%
Return on Invested Capital (ROIC)
27.07%28.94%22.28%13.75%1.04%-3.38%
Return on Capital Employed (ROCE)
16.40%16.40%14.30%10.60%0.80%-2.90%
Earnings Yield
6.37%5.09%3.06%2.10%0.25%-1.28%
FCF Yield
3.06%2.45%3.86%3.14%3.26%-0.70%
Dividend Yield
3.40%2.72%1.47%0.95%--
Payout Ratio
32.08%32.08%31.12%---
Buyback Yield / Dilution
-0.08%-0.08%-0.06%-0.08%--
Total Shareholder Return
3.32%2.64%1.41%0.86%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.